Tim Gallagher
Company: PhosphoGam
Job title: Chief Business Officer
Seminars:
Panel Discussion: Ensuring Lasting Therapeutic Responses from Allogeneic Therapy – Is Redosing the Way to Go? 8:30 am
Examine the role of redosing in sustaining therapeutic efficacy and preventing disease relapse in patients receiving allogeneic therapies How do we determine if multiple doses are needed and if so, how do we determine how many? Is it better to use a one and done model or plan for multiple doses? Analyze the impact of treatment…Read more
day: Conference Day Two
Maximizing Cell Viability by Preventing Exhaustion During Cell Expansion 1:45 pm
Explore innovative techniques to monitor cellular health and functionality throughout the expansion process Discover the impact of culture media and environmental factors on preventing cell fatigue and maintaining robust performanceRead more
day: Day Two - Track B PM
Chair’s Opening Remarks 8:00 am
day: Conference Day One
Industry Leaders’ Fireside Chat: Achieving Allogeneic Product Success by Aligning Innovation with Investor Expectations 8:10 am
An interactive panel discussion from the industry leaders of the field to set the scene on the allogeneic cell therapy space. Ask your questions live to understand the expert’s thoughts on key topics including: Evaluating key success factors for allogeneic therapies and how they differ from autologous approaches Discussing the role of clinical trial outcomes…Read more
day: Conference Day One
Close of Conference Day One 5:00 pm
day: Conference Day One